Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
6-Sep-2016Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysisRamaswami, R; Pinato, DJ; Kubota, K; Ishizuka, M; Arizumi, T, et al
1-Jan-2017Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational studyYen, C; Sharma, R; Rimassa, L; Arizumi, T; Bettinger, D, et al
1-Sep-2016The ALBI grade provides objective hepatic reserve phenotyping across each BCLC stage of hepatocellular carcinoma.Pinato, DJ; Sharma, R; Yen, C; Arizumi, T; Kubota, K, et al
24-Jan-2017The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug developmentPinato, DJ; Yen, C; Bettinger, D; Ramaswami, R; Arizumi, T, et al
18-Dec-2014Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed ModificationPinato, DJ; Arizumi, T; Allara, E; Jang, JW; Smirne, C, et al
2-Mar-2017On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective studyHowell, J; Pinato, DJ; Ramaswami, R; Bettinger, D; Arizumi, T, et al
14-Feb-2017Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.Howell, J; Pinato, DJ; Ramaswami, R; Arizumi, T; Ferrari, C, et al
26-May-2016Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative studyPinato, DJ; Arizumi, T; Jang, JW; Allara, E; Suppiah, PI, et al